Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)

• Company Description    LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. Number of Employees: 389

• Price / Volume Information    Yesterday's Closing Price: $3.08 Daily Weekly Monthly 20 Day Moving Average: 576,550 shares Shares Outstanding: 48.20 (millions) Market Capitalization: $148.46 (millions) Beta: 2.04 52 Week High: $7.32 52 Week Low: $2.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.92% -14.54% 12 Week -37.27% -38.61% Year To Date -9.68% -19.89%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 236 FIFTH AVENUE SUITE 400 - NEW YORK,NY 10001 USA ph: 866-351-5907 fax: - ir@lifemd.com http://www.lifemd.com

• General Corporate Information    Officers Justin Schreiber - Chief Executive Officer and Chairman Marc Benathen - Chief Financial Officer Roberto Simon - Director John Strawn - Director Joseph DiTrolio - Director Peer Information LifeMD, Inc. (CHCR) LifeMD, Inc. (ESRX) LifeMD, Inc. (MYDP) LifeMD, Inc. (COR) LifeMD, Inc. (GBCS) LifeMD, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 53216B104 SIC: 8011 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/16/26 Share - Related Items Shares Outstanding: 48.20 Most Recent Split Date: 10.00 (0.20:1) Beta: 2.04 Market Capitalization: $148.46 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.46 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/16/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 18.70 Price/Cash Flow: - Price / Sales: 0.73 EPS Growth vs. Year Ago Period: -166.67% vs. Previous Quarter: 20.00% Sales Growth vs. Year Ago Period: -24.01% vs. Previous Quarter: -5.75% ROE 06/30/26 - -168.23 03/31/26 - -150.88 12/31/25 - -83.93 ROA 06/30/26 - -31.27 03/31/26 - -22.59 12/31/25 - -7.85 Current Ratio 06/30/26 - 0.90 03/31/26 - 1.04 12/31/25 - 1.25 Quick Ratio 06/30/26 - 0.84 03/31/26 - 0.98 12/31/25 - 1.18 Operating Margin 06/30/26 - -10.19 03/31/26 - -7.21 12/31/25 - -2.37 Net Margin 06/30/26 - 0.10 03/31/26 - 2.37 12/31/25 - 6.58 Pre-Tax Margin 06/30/26 - -10.51 03/31/26 - -7.94 12/31/25 - -5.25 Book Value 06/30/26 - 0.16 03/31/26 - 0.32 12/31/25 - 0.48 Inventory Turnover 06/30/26 - 7.76 03/31/26 - 8.07 12/31/25 - 8.92 Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©